Clinical trial
Double Blind Placebo Controlled Pilot Trial of Memantine for Cognitive Impairment in Multiple Sclerosis
NCT00300716 is registered in ClinicalTrials.gov with Oregon Health and Science University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Double Blind Placebo Controlled Pilot Trial of Memantine for Cognitive Impairment in Multiple Sclerosis
- Lead sponsor
- Oregon Health and Science University
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- April 30, 2004
- Completion date
- January 31, 2009
- Enrollment
- 82 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.